| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PFE | Common Stock | Options Exercise | $325,530 | +12,716 | +190% | $25.60 | 19,393 | 26 Feb 2022 | Direct | F1 |
| transaction | PFE | Common Stock | Tax liability | $165,159 | -3,461 | -18% | $47.72 | 15,932 | 26 Feb 2022 | Direct | F2, F3 |
| transaction | PFE | Common Stock | Tax liability | $300,650 | -5,937 | -37% | $50.64 | 9,995 | 26 Feb 2022 | Direct | F4, F5 |
| holding | PFE | Common Stock | 27,860 | 26 Feb 2022 | By Rule 16b-3 Plan | ||||||
| holding | PFE | Common Stock | 8,532 | 26 Feb 2022 | By Spouse | F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PFE | Stock Appreciation Rights | Options Exercise | $0 | -12,716 | -100% | $0.000000* | 0 | 26 Feb 2022 | Common Stock | 12,716 | $25.60 | Direct |
| Id | Content |
|---|---|
| F1 | The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). |
| F2 | The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. |
| F3 | Price is the closing price of Pfizer common stock on February 25, 2022. |
| F4 | The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). |
| F5 | Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. |
| F6 | The reporting person disclaims beneficial ownership of the shares held by spouse. |